Clinical Trials in Ohio

Showing 9641-9660 of 15,929 trials

NK Cell Based Non-Myeloablative Transplantation in Acute Myeloid Diseases

NCT01370213

This is a phase II multi-institutional therapeutic study of NK-cell based nonmyeloablative haploidentical transplantation for the treatment of high-risk acute myeloid diseases. Enrollment will use a two-stage design. Stage 1 will enroll 15 patients unless an early stopping rule is met. If 9 or more of these first 15 patients achieve leukemia free neutrophil engraftment at day +28 accrual will move to stage 2. In stage 2, an additional 28 patients will be enrolled for a total of 43 patients. Patients will be followed for disease response for 2 years.

Acute Myeloid LeukemiaMyelodysplastic Syndrome

Masonic Cancer Center, University of Minnesota25 participantsStarted Sep 2011

Atlanta, Georgia, United States • Minneapolis, Minnesota, United States • St Louis, Missouri, United States +1 more locations

COMPLETEDPhase 232 miles

Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia

NCT01154816

This phase II trial is studying the side effects of and how well alisertib works in treating young patients with relapsed or refractory solid tumors or leukemia. Alisertib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.

HepatoblastomaPreviously Treated Childhood RhabdomyosarcomaRecurrent Childhood Acute Lymphoblastic Leukemia+8 more

Children's Oncology Group118 participantsStarted Feb 2011

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Little Rock, Arkansas, United States +102 more locations

NK Cell Based Non-Myeloablative Transplantation in Acute Myeloid Diseases

Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia

Find Trials by Condition in Ohio

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony)

To Assess the Safety and Activity of GBR 830, Compared to Placebo, in Adults With Moderate-to-severe Atopic Dermatitis

A Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate to Severe Plaque Psoriasis of the Scalp

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

Study of Carboplatin/Paclitaxel With or Without Investigational Drug (CS-7017) in Subjects With Metastatic Non-small Cell Lung Cancer

Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis

Study in Participants With Acute Migraines Headaches

A Long-Term Extension Study of OnabotulinumtoxinA (BOTOX®) for Urinary Incontinence Due to Neurogenic Detrusor Overactivity

Study to Evaluate the Safety and Efficacy of Filgotinib and Lanraplenib in Adults With Lupus Membranous Nephropathy (LMN)

Nortriptyline for Idiopathic Gastroparesis

Evaluation of Tofacitinib in Early Diffuse Cutaneous Systemic Sclerosis (dcSSc)

A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis

Clinical Evaluation of a Reusable Multifocal Optical Design in a Presbyopic Population

Direct Gloving Strategy: A Cluster-randomized Trial

A Study to Assess the Safety and Tolerability of Atezolizumab in Combination With Other Immune-Modulating Therapies in Participants With Locally Advanced or Metastatic Solid Tumors

Effectiveness and Acceptability of Stellate Ganglion Block for Posttraumatic Stress Disorder Symptoms - Effectiveness

A Phase I Study of AC220 in Patients With Relapsed/Refractory Acute Myeloid Leukemia Regardless of FLT3 Status